COLIN FARRITOR: Open Payments
NPI 1760062848 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 29 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $52 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $176 |
| Amgen Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $48 |
| Dexcom, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: QULIPTA, VRAYLAR, EVENITY, MOUNJARO, Dexcom G6 Transmitter, LEQVIO, INSPIRE, Veozah.
Industry payments across SD — which companies pay providers there.
